Author: Dyer, Wayne B; Zaunders, John J; Yuan, Fang Fang; Wang, Bin; Learmont, Jennifer C; Geczy, Andrew F; Saksena, Nitin K; McPhee, Dale A; Gorry, Paul R; Sullivan, John S
Title: Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection Document date: 2008_12_11
ID: 0ddutmdd_6
Snippet: While host genetic factors may predispose an individual for delayed disease progression, there is substantial evidence that antiviral T cell responses are required to sustain non-progressor status. Earlier studies have demonstrated an important role for Gag-specific CTL in delaying disease progression [20, 21] . Non-progressors that control viraemia in the absence of antiviral therapy also have strong CD4 T cell proliferative responses to the Gag.....
Document: While host genetic factors may predispose an individual for delayed disease progression, there is substantial evidence that antiviral T cell responses are required to sustain non-progressor status. Earlier studies have demonstrated an important role for Gag-specific CTL in delaying disease progression [20, 21] . Non-progressors that control viraemia in the absence of antiviral therapy also have strong CD4 T cell proliferative responses to the Gag protein p24 [22] . Importantly, for Gag CTL to be efficient in killing HIV-infected cells and therefore protective in controlling viraemia, these must also be accompanied by p24-specific T cell proliferative responses [23] [24] [25] . Appropriate T cell help is also required to achieve maturation and display of effector phenotypes on CTL associated with effective virological control [26] .
Search related documents:
Co phrase search for related documents- antiviral therapy and cell response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
- antiviral therapy and disease progression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
- antiviral therapy and early study: 1, 2, 3, 4, 5, 6
- antiviral therapy and important role: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
- cell help and delayed disease progression: 1
- cell help and disease progression: 1, 2, 3
- cell help and early study: 1
- cell help and effector phenotype: 1
- cell help and important role: 1, 2, 3, 4, 5, 6
Co phrase search for related documents, hyperlinks ordered by date